Welcome to PricewaterhouseCoopers' Pharma and Life Sciences tax news. Published by our global pharmaceuticals & life sciences industry group, these informational bulletins will periodically review developing tax issues, new IRS pronouncements and tax legal rulings that affect the pharmaceutical and healthcare products industry.
-
Pharma and Life Sciences Tax News: Vol. 7, No. 9: IRS Addresses Election, Calculation of Alternative Simplified Research Credit - 2 July 2008
-
Pharma and Life Sciences Tax News: Vol. 7, No. 8: New ruling on character of medicaid rebates; Timing issue not addressed - 18 June 2008
-
Pharma and Life Sciences Tax News: Vol. 7, No. 7: General information on the new R&D law in Turkey - 29 April 2008
-
Pharma and Life Sciences Tax News: Vol. 7, No. 6: Roche Products Pty Limited v The Commissioner of Taxation: A bitter pill to swallow, but for whom? - 28 April 2008
-
Pharma and Life Sciences Tax News: Vol. 7, No. 5: The new French R&D tax credit system gives a good signal - 25 April 2008
-
Pharma and Life Sciences Tax News: Vol. 7, No. 4: Second IRS industry directive on Section 936 exit strategies - 22 February 2008
-
Pharma and Life Sciences Tax News: Vol. 7, No. 3: New research credit calculation method for 2007: Consequences of credit lapse - 21 February 2008
-
Pharma and Life Sciences Tax News: Vol. 7, No. 2: Recent changes to increase Ireland’s attractiveness - 14 February 2008
-
Pharma and Life Sciences Tax News: Vol. 7, No. 1: Compulsory discounts and turnover tax adjustments: Decision of the Baden-Württemberg Finance Court dated 6/11/2007 - 31 January 2008
-
Pharma Tax News: Vol. 6, No. 11: Luxembourg as a situs for pharma R&D activities for pharma companies? - 27 November 2007
-
Pharma Tax News: Vol. 6, No. 10: IRS official comments on transfer pricing service audits - 26 November 2007
-
Pharma Tax News: Vol. 6, No. 9: Section 965 foreign earnings repatriation LMSB directive - 20 November 2007
-
Pharma Tax News: Vol. 6, No. 8: New senate bill proposes significant changes to research credit - 23 October 2007
-
Pharma Tax News: Vol. 6, No. 7: IRS issues coordinated issues paper on buy-in royalties under existing regulations: Some insights on its impact on pharmaceutical and biotechnology companies - 22 October 2007
-
Pharma Tax News: Vol. 6, No. 6: Industry directive targets inappropriate deductions for governmental agency agreements - 28 June 2007
-
Pharma Tax News: Vol. 6, No. 5: New IRS directive provides guidelines for treatment of biotech and pharma agreements - 4 June 2007
-
Pharma Tax News: Vol. 6, No. 4: New tax measure in Belgium – 80% tax deduction for patent income - 25 May 2007
-
Pharma Tax News: Vol. 6, No. 3: IRS industry directive and audit guidelines regarding certain intangible property migrations - 15 February 2007
-
Pharma Tax News: Vol. 6, No. 2: New list of duty free products and chemicals for the pharmaceutical industry - 30 January 2007
-
Pharma Tax News: Vol. 6, No. 1: Changes to the research tax credit calculation will provide long-awaited tax relief to pharmaceutical companies - 17 January 2007
- Pharma tax news: Vol. 5, No. 11: Tax relief and health care act of 2006 expands sec. 199 manufacturing deduction to Puerto Rico - 27 December 2006
- Pharma tax news: Vol. 5, No. 10: IRS comments on issues for the pharmaceutical, biotech, healthcare and medical device industries - 21 December 2006
- Pharma tax news: Vol. 5, No. 9: Capitalisation of contingent royalties - 1 November 2006
- Pharma tax news: Vol. 5, No. 8: New temporary regulations address key Section 482 rules - 6 September 2006
- Pharma tax news: Vol. 5, No. 7: Accounting for uncertainty in income taxes, FAS B interpretation No. 48 from a 482 perspective - 15 August 2006
- Pharma tax news: Vol. 5, No. 6: Signs of increased focus on regulatory compliance in Poland - 21 June 2006
- Pharma tax news: Vol. 5, No. 5: Signs of increased focus on regulatory compliance in Poland - 14 April 2006
- Pharma tax news: Vol. 5, No. 4: New IRS Chief Counsel advice signals possible change in IRS’ treatment of related party receipts for R&D credit - 14 March 2006
- Pharma tax news: Vol. 5, No. 3: IRS issues TAM on like-kind exchanges of foreign and domestic intangibles - 6 March 2006
- Pharma tax news: Vol. 5, No. 2: President Bush renews call for extending tax cuts, including permanent research credit, in “American Competitiveness Initiative” - 9 February 2006
- Pharma tax news: Vol. 5, No. 1: Tax reconciliation bills would extend and modify research credit - 4 January 2006
|
|
